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STRESS AND APPETITE
Eating is thought to be suppressed during stress
due to anorectic effects of corticotrophin releasing
hormone, and increased during recovery from stress
due to appetite stimulating effects of residual corti-
sol (1). Cortisol clearly plays an important role in
energy regulation, increasing available energy through
gluconeogenesis and lipolysis. Glucocorticoids lead
to hyperphagia and weight gain, and are necessary
for the expression of their obesity (2).
Several studies have shown that people under
chronic stress tend to gain weight over time, which
may be due to both stress- related endocrine chang-
es, as well as coping behaviors (3). It was hypothe-
sized that high cortisol reactivity in response to
stress may lead to eating after stress, given the
relations between cortisol with both psychological
stress and mechanisms affecting hunger. High cortisol
reactors consumed more energy on the stress day
compared to low reactors, high reactors ate signifi-
cantly more sweet food across days. Increases in
negative mood in response to the stressors were also
significantly related to greater food consumption.
Thus, psychophysiological response to stress in-
fluences subsequent eating behavior. In the cur-
rent study of college undergraduate women (4),
dieting was related to eating less during a control
day, whereas cortisol reactivity predicted eating
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more on a stress day. Multiple comparisons of food
type consumed by reactivity group revealed fur-
ther differences of the sweet food consumed after
stress, the high reactors consumed significantly
more high fat food.
STRESS AND IMPAIREDCARBOHYDRATE
AND LIPID METABOLISM
Responses to mental stress involves activation
of the sympathetic nervous system and secretion
of epinephrine from the adrenal medulla and acti-
vation of the hypothalamo-pituitary adrenal axis,
the latter resulting in the secretion of glucocorti-
coids from the adrenal cortex. The combined ef-
fects of these neuroendocrine alterations are the
mobilization of lipids from the adipose tissue and
of glucose from hepatic glycogen to ensure ample
energy availability together with the development
of an acute state of insulin resistance, which di-
verts glucose away from skeletal muscle to ensure
glucose supply to the brain.
Mental stress significantly enhances plasma cate-
cholamine and cortisol concentrations, but does
not acutely impair insulin sensitivity (5). Repeated
mental stress may lead to chronic alterations in
cortisol and catecholamine concentrations and to
insulin resistance. Furthermore, chronically ele-
vated cortisol concentrations may favour the de-
velopment of abdominal obesity and of the meta-
bolic syndrome (6, 7) (Fig. 1). Repeated mental
stress particularly in obese patients can contribute
to increased blood pressure and to increased plasma
glucose concentrations.
STRESS AND INFLAMMATION
It has been recognized that low-grade, chronic
inflammation is present in individuals at risk of
developing atherosclerotic disorders (8). Obese
insulin-resistant individuals show increased tumor
necrosis fantor-α(TNF-α) and interleukin (IL) con-
centrations in plasma, adipose tissue and skeletal
muscle (9-11). TNF-α and other pro-inflammatory
cytokines acutely reduced insulin sensitivity (12-
14). Dietary factors can modulate the expression
of these cytokines in insulin-sensitive tissue. In
particular, a high-fat diet appears to reduce insulin
sensitivity by activating inflammatory responses in
adipose tissue through the stimulation of the in-
hibitor of nuclear factor kappa B (NF-kB) (15).
Several studies demonstrated that psychological
stress stimulates the production of pro-inflammatory
cytokines. In elderly individuals, the chronic stress
of looking after a dementing spouse led to increased
plasma IL-6 concentrations. Raised plasma concen-
trations of pro-inflammatory cytokines were re-
corded in individuals expecting an academic ex-
amination (16). Both chronic psychological stress
and acute mental stress have been demonstrated
to increase pro-inflammatory cytokines (17, 18).
The pathways responsible for the stimulation of
cytokine release involve activation of the sympathetic
nervous system (19). In humans, mental stress acutely
activated NF-kB, a nuclear factor acting upstream
of the inflammatory cascade, in peripheral blood
mononuclear cells (20).
OXIDATIVE STRESS AND INSULIN RE-
SISTANCE
Obese subjects with type 2 diabetes, especially soon
after the onset of diabetes, usually exhibit postprandial
hyperglycemia with delayed hyperinsulinemia. It
is recognized that insulin resistance causes postpran-
dial hyperglycemia (21, 22) ; however, it is also possi-
ble that impairment of early insulin secretion in
response to an oral glucose load is the reason why
postprandial hyperglycemia occurs (23). Since even
modest increases in postprandial glucose values
can be a risk factor for cardiovascular disease (24),
patients with diabetes would probably benefit from
early and effective mealtime treatment. The meal-
induced activation of homeostasis in patients with
type 2 diabetes can be reduced by decreasing post-
prandial hyperglycemia (25).
Stress
Epinephrine (adrenal medulla)
Glucocorticoid (adrenal cortex)
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metabolic syndrome
Fig. 1 Mental stress leads to insulin resistance and to the
metabolic syndrome.
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Oxidative stress is widely invoked as a patho-
genic mechanism for atherosclerosis. Among the
sequelae of hyperglycemia, oxidative stress has
been suggested as a potential mechanism for ac-
celerated atherosclerosis (26-28). Hyperglycemia
can increase oxidative stress through several path-
ways. A major mechanism appears to be the hyper-
glycemia-induced intracellular reactive oxygen species
(ROS), produced by the proton electromechanical
gradient generated by the mitochondria electron
transport chain and resulting in increased produc-
tion of superoxide (26). Oxidative stress impairs
glucose uptake in muscle and fat (29-30) and de-
creases insulin secretion from pancreatic β cells (31).
It has been demonstrated in nondiabetic human
subjects that fat accumulation closely correlated
with the markers of systemic oxidative stress and
that plasma adiponectin levels correlated inversely
with systemic oxidative stress (32). Those are in
good agreement with data suggesting that systemic
oxidative stress correlates with BMI (33, 34). It is
suggested that increased ROS secretion into pe-
ripheral blood from accumulated fat in obesity is
also involved in induction of insulin resistance in
skeletal muscle and adipose tissue, impaired insulin
secretion by β cells.
Therefore, strategies to reduce postprandial hyper-
glycemia and hyperinsulinemia represent an im-
portant approach to improving glycemic control in
patients with type 2 diabetes mellitus and may
even prevent the deterioration of glucose metabo-
lism in impaired glucose tolerance and the subse-
quent progression to diabetes.
PREPARATION OF PALATINOSE BASED
FUNCTIONAL FOOD
Palatinose (isomaltulose), which is present in
honey, has shown promise as a noncariogenic ca-
loric sweetener (35, 36). A previous study clearly
demonstrated that the increase in plasma glucose
(PG) and insulin (IRI) after palatinose ingestion
was significantly smaller than that after sucrose
(37). Furthermore, palatinose has been shown to
be an insulin-sparing caloric sweeteer with a lower
glycemic index than sucrose in type 2 diabetic pa-
tients and streptozotocin-diabetic animals (38, 39).
The difference may be due to a difference in di-
gestibility because palatinose is digested to glu-
cose and fructose by the intestinal isomaltase, and
the hydrolysis of palatinose by a homogenate of
human intestinal mucosa was one-fourth that of
sucrose (40). However, palatinose was completely
cleaved and absorbed (41).
The novel enteral liquid formula designated as
Inslow was prepared by the replacement of dex-
trin in the standard balanced formula (SBF) with
55.7% palatinose among carbohydrate (Table 1)
(41). Inslow contains palatinose, branched dextrin,
xylitol, and other carbohydrates containing dietary
fiber and mixed carbohydrates from raw material
as the principal carbohydrates, and the percent-
ages of protein, fat, and carbohydrate in the for-
mula are 20%, 29.7%, and 50.3%, respectively. The
commercially available SBF that was used for com-
parison contains dextrin and sucrose as the princi-
pal carbohydrates, and the percentages of protein,
fat, and carbohydrate are 16%, 25%, and 59%, re-
Table 1 Composition of Inslow and standard balanced formula (SBF)
Inslow
○ Energy 1 kcal/ml 1 kcal/ml
○ Protein 20.0％ 6.0%
○ Fat 29.7％ 25.0%
SFA 9.5％ 9.0%
MUFA 68.5％ 45.0%
PUFA 16.8％ 40.0%
○ Carbohydrate 50.3％ 59.0%
Maltodextrin 22.8％ Sucrose 2.8%
Xylitol 8.9％ Dextrin 97.2%
Paratinose 68.3%
Abbreviations : SFA, saturated fatty acid ; MUFA, monounsaturated fatty acid ; PUFA, polyunsaturated fatty acid
Standard balanced
formula(SBF)
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spectively. Spray-dried powder versions of Inslow
and SBF were prepared for use in the long term
study.
CONTROLOFMETABOLIC HOMEOSTASIS
BY THE SUPPRESSION OF POSTPRAN-
DIAL HYPERGLYCEMIA
The effect of Inslow on carbohydrate and lipid
metabolism in Sprague-Dawley rats were com-
pared with those of SBF (42). After a bolus intra-
gastric injection of each formula equivalent to 0.9
g/kg carbohydrate, the peak levels of PG and IRI
in the femoral vein of the Inslow group were sig-
nificantly smaller than those of SBF group (Fig.
2). The values of total incremental area (area un-
der the curve : AUC) of PG and IRI from the basal
level for 120 min after INSLOW ingestion were
significantly smaller than that after SBF ingestion
(Fig. 3).
From 20 to 27 weeks of age, daily food intake
and body weight did not differ significantly among
the Inslow and SBF groups ; however, body weight
gain in the Inslow group was lower than in SBF
group. After ingestion of Inslow or SBF for two
months, fasting PG levels were not different among
the two groups, but the IRI level in the Inslow
group was significantly lower than that in the SBF
group. The TG level markedly decreased by 34%
in the Inslow group and increased by 23% in the SBF
group. The TG level of the Inslow group was sig-
nificantly lower than that of the SBF group. The
concentrations of serum free fatty acid (FFA) and total
cholesterol did not differ among the two groups.
The weights of epididymal, mesenteric, and retro-
peritoneal adipose tissues were significantly lower
in the Inslow group than in the SBF group. The
weights of liver and pancreas in the Inslow group
were higher than in the SBF group. The concen-
tration of TG in the liver in the Inslow group was
significantly lower than that in the SBF group.
Insulin sensitivity in the Inslow and SBF groups
was evaluated by the hyperinsulinemic euglycemic
clamp test with oral glucose load. The glucose in-
fusion rate (GIR), which reflected the insulin sen-
sitivity in peripheral tissues, of the Inslow group
was significantly higher than that of the SBF group
(A) (B)
Fig. 2 Changes in plasma glucose (PG) (A) and plasma insulin (IRI) (B) in the femoral vein after oral administration of
Inslow (white circles) and SBF (black squares). Values are means ± SE for n=10. ＊ : p<0.001 (vs. Inslow)
Fig. 3 Area under the curve (AUC) after 120 min of PG and
IRI in the femoral vein during oral administration of Inslow
(white bar) or SBF (black bar). Values are means ± SE for
n=10. † : p<0.01 (vs. Inslow)
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(Fig. 4). The rate of hepatic glucose uptake (HGU),
which might reflect insulin sensitivity in the liver,
was significantly higher in the Inslow group than
in the SBF group (Fig. 4).
CONCLUSION
Postprandial glucose and insulin levels affects
body weight and body fat even though the intake
was same amount of energy. The effects of Inslow
could be due to the suppression of the excess calo-
ries exposed in adipocytes which was controlled
by insulin. In addition, increased ROS production
observed by postprandial hyperglycemia leads to
increased oxidative stress in blood and other organs.
Both metabolic and epidemiologic evidence sug-
gest that replacing high-glycemic-index forms of
carbohydrate with low-glycemic-index carbohydrates
could reduce the risk of type 2 diabetes (43). Dif-
ferences in the pattern of postprandial glucose
response offer a potential explanation for the con-
flicting results on insulin sensitivity, with possibil-
ity that increases in insulin exposure may affect
insulin sensitivity through down-regulation of insu-
lin action (44). Therefore, it is suggested that Inslow
which suppresses postprandial glucose level is ben-
eficial for both stress and metabolic controls.
ACKNOWLEDGEMENTS
This work was supported in part, by Grants-in-
Aid for Scientific Research from the Ministry of
Education, Culture, Sports, Science, and Technol-
ogy in Japan and the 21 st Cenrury COE Program,
Human Nutritional Science and Stress Control,
Tokushima, Japan.
REFERENCES
1. Sapolsky R : Why Zebras don’t get Ulcers : An
Updated Guide to Stress, Stress-related Dis-
eases, and Coping. Freeman and Co, New
York, 1998, pp.76-79
2. Bray G : Autonomic and endocrine factors in
the regulation of food intake. Brain Research
Bulletin 14 : 505-510, 1985
3. Greeno C, Wing R, Matthews K, Vitaliano P :
Stress predicts overeating and weight gain out-
side of the laboratory : data from multiple stu-
dies. Annals of Behavioral Medicine 20 : S 032,
1998
4. Epel E, Lapidus R, McEwen B, Brownell K :
Stress may add bite to appetite in women : a
laboratory study of stress-induced cortisol and
eating behavior. Psychoneuroendocrinol 26 :
37-49, 2001
5. Seematter G, Guenat E, Schneiter P, Cayeux
C, Jequier E, Tappy L : Effects of mental stress
on insulin-mediated glucose metabolism and
energy expenditure in lean and obese women.
American Journal of Physiology 279 : E799-E
805, 2000
6. Bjorntorp P : The regulation of adipose tissue
distribution in humans. International Journal
of Obesity and Related Metabolic Disorders
20 : 291-302, 1996
7. Masuzaki H, Paterson J, Shinyama H, Morton
NM,Mullins JJ, Seckl JR, Flier JS : A transgenic
model of visceral obesity and the metabolic
syndrome. Science 294 : 2166-2170, 2001
8. Casscells W, Naghavi M, Willerson JT : Vul-
nerable atherosclerotic plaque : a multifocal dis-
ease. Circulation 107 : 2076-2077, 2003
9. Hotamisligil GS, Arner P, Caro JF, Atkinson
RL, Spiegelman BM : Increased adipose tis-
sue expression of tumor necrosis factor-a in
human obesity and insulin resistance. The Jour-
nal of Clinical Investigation 95 : 2409 -2415,1995
10. Hotamisligil GS, Shargill NS, Spiegelman BM :
Adipose expression of tumor necrosis factor-
alpha ; direct role in obesity-linked insulin re-
sistance. Science 259 : 87-91, 1993
11. Saghizadeh M, Ong JM, Garvey WT : The ex-
Fig. 4 Glucose infusion rate (A) and hepatic glucose uptake
(B) during hyperinsulinemic euglycemic clamp with oral
glucose load in Inslow (white bar) and SBF (black bar) groups.
Values are means ± SE for n=10. ＊ : p<0.05 (vs. Inslow)
２６３The Journal of Medical Investigation Vol. 52 Supplement November 2005
pression of TNF-a by human muscle : rela-
tionship to insulin resistance. The Journal of
Clinical Investigation 97 : 1111-1116, 1996
12. Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K,
Olefsky JM:TNF-alpha-induced insulin resistance
in vivo and its prevention by troglitazone. Diabetes
46 : 1678-1683, 1997
13. Ruan H, Miles PD, Ladd CM, Ross K, Golub
TR, Olefsky JM, Lodish HF : Profiling gene
transcription in vivo reveals adipose tissue as
an immediate target of tumor necrosis factor-
alpha : implications for insulin resistance. Dia-
betes 51 : 3176-3188, 2002
14. van Hall G, Steensberg A, Sacchetti M, Fischer
C, Keller C, Schjerling P, Hiscock N, Moller
K, Saltin B, Febbraio MA, Pedersen BK :
Interleukin-6 stimulates lipolysis and fat oxi-
dation in humans. The Journal of Clinical
Endocrinology & Metabolism 88 : 3005-3010, 2003
15. Yuan M, Konstantopoulos N, Lee J, Hansen L,
Li ZW, Karin M, Shoelson SE : Reversal of
obesity and diet-induced insulin resistance with
salicylates or targeted disruption of Ikkb. Sci-
ence 293 : 1673-1677, 2001
16. Maes M, Van der Planken M, Van Gastel A,
Bruyland K, Van Hunsel F, Neels H, Hendriks
D, Wauters A, Demedts P, Janca A, Scharpe
S : Influence of academic examination stress on
hematological measurements in subjectively
healthy volunteers. Psychiatry Research 80 :
201-212, 1998
17. Steptoe A, Willemsen G, Owen N, Flower L,
Mohamed-Ali V : Acute mental stress elicits
delayed increases in circulating inflammatory
cytokine levels. Clinical Science 101:185-192, 2001
18. Steptoe A, Owen N, Kunz-Ebrecht S, Mohamed-
Ali V : Inflammatory cytokines, socioeconomic
status, and acute stress responsivity. Brain Be-
havior and Immunity 16 : 774-784, 2002
19. Tracey KJ : The inflammatory reflex. Nature
420 : 853-859, 2002
20. Bierhaus A, Wolf J, Andrassy M, Rohleder N,
Humpert PM, Petrov D, Ferstl R, von Eynat-
ten M, Wendt T, Rudofsky G, Joswig M, Mor-
cos M, Schwaninger M, McEwen B, Kirsch-
baum C, Nawroth PP : A mechanism convert-
ing psychosocial stress into mononuclear cell
activation. Proceedings of the National Acad-
emy of Sciences of the United States of Amer-
ica 100 : 1920-1925, 2003
21. Lillioja S, Mott DM, Howard BV, Bennett PH,
Yki-Jarvinen H, Freymond D, Nyomba BL,
Zurlo F, Swinburn B, Bogardus C : Impaired
glucose tolerance as a disorder of insulin ac-
tion : Longitudinal and cross-sectional studies
in Pima Indians. New England Journal of Medi-
cine 318 : 1217-1225, 1988
22. Reaven G, Miller R : Study of the relationship
between glucose and insulin responses to an
oral glucose load in man. Diabetes 17:560-569, 1968
23. Bruce DG, Chisholm DJ, Storlien LH, Kraegen
EW : Physiological importance of deficiency
in early prandial insulin secretion in non-insulin-
dependent diabetes. Diabetes 37 : 736-744, 1988
24. United Kingdom Prospective Diabetes Study
(UKPDS). 13 : relative efficacy of randomly al-
located diet, sulphonylurea, insulin, or met-
formin in patients with newly diagnosed non-
insulin-dependent diabetes followed for three
years. British Medical Journal 310:83-88, 1995
25. DiMarchi RD, Chance RE, Long HB, Shields
JE, Slieker LJ : Preparation of an insulin with
improved pharmacokinetics relative to human
insulin through consideration of structural ho-
mology with insulin-like growth factor l. Hor-
mone Research 41 (Suppl 2) : 93-96, 1994
26. Nishikawa T, Edelstein D, Du XL, Yamagishi S,
Matsumura T, Kaneda Y, Yorek MA, Beebe
D, Oates PJ, Hammes HP, Giardino I, Brownlee
M : Normalizing mitochondria) superoxide pro-
duction blocks three pathways of hypergly-
caemic damage. Nature 404 : 787-790, 2000
27. Baynes JW, Thorpe SR : Role of oxidative stress
in diabetic complications : a new perspective
on an old paradigm. Diabetes 48 : 1-9, 1999
28. Baynes JW : Role of oxidative stress in devel-
opment of complications in diabetes. Diabetes
40 : 405-412, 1991
29. Maddux BA, See W, Lawrence JC Jr, Goldfine
AL, Goldfine ID, Evans JL : Protection against
oxidative stress-induced insulin resistance in
rat L6 muscle cells by micromolar concentrations
of α-lipoic acid. Diabetes 50 : 404-410, 2001
30. Rudich A, Tirosh A, Potashnik R, Hemi R,
Kanety H, Bashan N : Prolonged oxidative
stress impairs insulin-induced GLLJT 4 trans-
location in 3T3-L1 adipocytes. Diabetes 47 :
1562-1569, 1998
31. Matsuoka T, Kajimoto Y, Watada H, Kaneto
H, Kishimoto M, Umayahara Y, Fujitani Y,
Kamada T, Kawamori R, Yamasaki Y : Glycation-
dependent, reactive oxygen species-mediated
suppression of the insulin gene promoter ac-
tivity in HIT cells. The Journal of Clinical In-
E. Takeda, et al. Controls of oxidative stress and postprandial hyperglycemia２６４
vestigation 99 : 144-150, 1997
32. Furukawa S, Fujita T, Shimabukuro M, Iwaki
M, Yamada Y, Nakajima Y, Nakayama O,
Makishima M, Matsuda M, Shimomura I :
Increased oxidation stress in obesity and its
impact on metabolic syndrome. The Journal
of Clinical Investigation 114 : 1752-1764, 2004
33. Keaney JF Jr, Larson MG, Vasan RS, Wilson
PW, Lipinska I, Corey D, Massaro JM, Suth-
erland P, Vita JA, Benjamin EJ : Obesity and
systemic oxidative stress : clinical correlates
of oxidative stress in the Framingham Study.
Arteriosclerosis Thrombosis and Vascular Bio-
logy 23 : 434-439, 2003
34. Olusi SO : Obesity is an independent risk
factor for plasma lipid peroxidation and deple-
tion of erythroryte cytoprotective enzymes in
humans. International Journal of Obesity and
Related Metabolic Disorders 26 : 1159-1164, 2002
35. Siddiqui IR, Furgala B : Isolation and charac-
terization of oligosaccharides from honey. Part 1.
Disaccharides. J Api Res 6 : 39-145, 1967
36. Lingstrom P, Lundgren F, Birkhed D, Takazoe
I, Frostell G : Effects of frequent mouthrinses
with palatinose and xylitol on dental plaque.
European Journal of Oral Sciences 105 : 162-
169, 1997
37. Kawai K, Okuda Y, Yamashita K : Changes in
blood glucose and insulin after an oral palati-
nose adlninistration in normal subjects. Endo-
crinologia Japonica 32 : 933-936, 1985
38. Kawai K, Yoshikawa H, Murayama Y, Okuda
Y, Yamashita K : Usefulness of palatinose as a
caloric sweetener for diabetic patients. Hor-
mone and Metabolic Research 21 : 338-340, 1989
39. Okuda Y, KawaiK,ChibaY,KoideY,YamashitaK:
Effects of parenteral palatinose on glucose me-
tabolism in normal and streptozotocin diabetic
rats. Hormone and Metabolic Research 18 :
361-364, 1986
40. Dahlquist A, Auricchio S, Semenza G, Prader
A : Human intestinal disaccharidases and he-
reditary disaccharide intolerance : The hydro-
lysis of sucrose, isomaltose, palatinose (iso-
maltulose), and 1,6-α -oligosaccharid(isomalto-
oligosaccharide) preparation. The Journal of
Clinical Investigation 42 : 556-562, 1963
41. Lina BAR, Jonker D, Kozianowski G : Isomal-
tulose (palatinose) : a review of biological and
toxicological studies. Food and Chemical Toxi-
cology 40 : 1375-1381, 2002
42. Arai H, Mizuno A, Matsuo K, Fukaya M,
Sasaki H, Arima H, Matsuura M, Taketani Y,
Doi T, Takeda E : Effect of a Novel Palatinose-
Based Liquid Balanced Formula (MHN-01)
on Glucose and Lipid Metabolism in Male
Sprague-Dawley Rats After Short-and Long-
Term Ingestion. Metabolism 53(8) : 977-983, 2004
43. Peters AL, Davidson MB : Effects of various
enteral feeding products on postprandial blood
glucose response in patients with type 1 dia-
betes. The Japanese Journal of Parenteral and
Enteral Nutrition 16 : 69-74, 1992
44. Craig LD, Nicholson S, Silverstone FA, Kennedy
RD : Use of a reduced-carbohydrate, modified-
fat enteral formula for improving metabolic
control and clinical outcomes in long-term care
residents with type 2 diabetes : Results of a
pilot trial. Nutrition 14 : 529-534, 1998
２６５The Journal of Medical Investigation Vol. 52 Supplement November 2005
